Małgorzata Krześniak

发表

Influence of DNA repair gene polymorphisms on prognosis in inoperable non‐small cell lung cancer patients treated with radiotherapy and platinum‐based chemotherapy

D. Butkiewicz, R. Suwiński, A. Drosik, 2012, International journal of cancer.

Germline Variants in Angiogenesis-Related Genes Contribute to Clinical Outcome in Head and Neck Squamous Cell Carcinoma

A. Gdowicz-Kłosok, D. Butkiewicz, T. Rutkowski, 2022, Cancers.

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy

A. Gdowicz-Kłosok, D. Butkiewicz, Małgorzata Marszałek-Zeńczak, 2021, International journal of molecular sciences.

Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin.

A. Gdowicz-Kłosok, D. Scieglinska, M. Rusin, 2015, Cellular signalling.

DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients

D. Butkiewicz, T. Rutkowski, Agnieszka Gdowicz-Kłosok, 2023, Cancers.

Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand

M. Głowala‐Kosińska, Barbara Łasut-Szyszka, Agnieszka Gdowicz-Kłosok, 2024, Apoptosis.

Rapamycin prevents strong phosphorylation of p53 on serine 46 and attenuates activation of the p53 pathway in A549 lung cancer cells exposed to actinomycin D

M. Rusin, M. Krześniak, I. Matuszczyk, 2014, Mechanisms of Ageing and Development.

Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol

D. Butkiewicz, M. Głowala‐Kosińska, M. Rusin, 2013, Molecular Biology Reports.

Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML

C. Harris, D. Butkiewicz, M. Benedyk, 2007, Mechanisms of Ageing and Development.

PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a.

A. Gdowicz-Kłosok, M. Rusin, M. Krześniak, 2018, Archives of biochemistry and biophysics.

Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activity

A. Gdowicz-Kłosok, M. Głowala‐Kosińska, M. Rusin, 2021, International journal of molecular sciences.

The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein

A. Gdowicz-Kłosok, M. Rusin, Patryk Janus, 2018, Neuroscience Letters.

Transcriptomic and proteomic study of cancer cell lines exposed to actinomycin D and nutlin-3a reveals numerous, novel candidates for p53-regulated genes.

M. Pietrowska, Barbara Łasut-Szyszka, M. Gawin, 2024, Chemico-biological interactions.